NCT04596163

Brief Summary

Sternotomy pain is usually significant after cardiac surgery. Analgesic options for sternotomy in cardiac surgery are often limited. Poorly controlled acute pain is an important factor to development of chronic postsurgical pain. The transversus thoracis muscle plane (TTP) block is a novel technique that provides analgesia to anterior chest wall. A double-blinded RCT is conducted to assess the efficacy of applying TTP block as an adjunct to analgesia in cardiac surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
86

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 6, 2020

Completed
9 days until next milestone

Study Start

First participant enrolled

October 15, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 22, 2020

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 22, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 22, 2023

Completed
Last Updated

July 13, 2023

Status Verified

July 1, 2023

Enrollment Period

2 years

First QC Date

October 6, 2020

Last Update Submit

July 12, 2023

Conditions

Keywords

Regional anaesthesiaCardiac surgery

Outcome Measures

Primary Outcomes (1)

  • Opioid consumption

    The total amount of opioid (mg) used during the surgery

    Once at the end of the surgery

Secondary Outcomes (10)

  • Percentage blood pressure change

    From 5 minutes before skin incision to 10 minutes after skin incision at 1 minute interval ( a total of 15 time point)

  • Percentage heart rate change

    From 5 minutes before incision to 10 minutes after skin incision at 1 minute interval (a total of 15 time points)

  • Morphine consumption

    up to 72 hours postoperatively

  • Length of hospital stay

    Immediately after the surgery up to the day of patient discharge

  • Intensive Care unit (ICU) stay

    Immediately after the surgery up to the time of ICU discharge

  • +5 more secondary outcomes

Study Arms (2)

Intervention

ACTIVE COMPARATOR

Ultrasound guided Regional block using 0.25% levobupivacaine (local anaesthetic agent) 20ml (50mg) on each side of the sternum over 1-2 minutes after general anaesthesia before surgery.

Procedure: Transversus thoracis muscle plane block

Control

PLACEBO COMPARATOR

Ultrasound guided Regional block using 20ml of 0.9% normal saline on each side of the sternum after general anaesthesia before surgery.

Procedure: Transversus thoracis muscle plane block

Interventions

After general anaesthesia, transversus thoracis plane (TTP) block, a kind of regional block will be performed near both sides of the sternum under ultrasound guidance using either levobupivacaine or normal saline to both groups of patients. The end point for injection is the fluid spread along the plane just superficial to the transversus thoracis muscle, together with the downward displacement of the pleura.

ControlIntervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elective CABG, aortic valve repair/replacement, mitral valve repair/replacement, or combined CABG/valve procedure

You may not qualify if:

  • emergency surgery
  • redo surgery
  • history of thoracotomy or mastectomy
  • history of chronic pain or regular analgesic use (except paracetamol and NSAID)
  • history of psychiatric illnesses or illicit drug use
  • renal failure with eGFR \<30ml/min or on renal replacement therapy
  • mortality or require re-sternotomy within 24h after operation
  • intraoperative use of remifentanil
  • unable to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prince of Wales Hospital

Hong Kong, Hong Kong

Location

MeSH Terms

Conditions

Pain, PostoperativeSurgical WoundCardiovascular Diseases

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsWounds and Injuries

Study Officials

  • Henry Man Kin Wong, MBChB

    Chinese University of Hong Kong

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Single-centred, double-blinded, randomized, placebo-controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Honorary Clinical Assistant Professor

Study Record Dates

First Submitted

October 6, 2020

First Posted

October 22, 2020

Study Start

October 15, 2020

Primary Completion

October 22, 2022

Study Completion

April 22, 2023

Last Updated

July 13, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations